Skyscape Web Viewer : Radiation Oncology Question Review : Main Index

View All
About
Altered fractionation
Amifostine Question 1.12 Answer 1.12
Anaplastic gliomas 1p19q deletion, impact of bromodeoxyuridine (BUdR) therapy incidence rate temozolomide in anaplastic oligodendrogliomas chemotherapy radiation therapy for treatment for
ANITA trial
Arteriovenous malformation risk of hemorrhage following radiosurgery stereotactic radiosurgery (SRS) implications for not treating Spetzler-martin grading scheme toxicities associated with SRS
Bevacizumab Answer 2.101 Question 2.101
Bilateral diagnostic mammogram Question 3.25 Question 3.26
Biliary tract malignancy
Bladder cancer bladder preservation treatment chemotherapy to definitive radiation contraindications with chemoradiation patients outcomes with transitional cell carcinoma of, site for adenocarcinoma of, site for chemoRT, OS for cisplatinum-based chemoradiation neoadjuvant chemotherapy TN staging treatment planning with radiation
Brachytherapy Answer 7.114 GEC-eSTRO dose guidelines LDR vs HDR Answer 7.115 ICRU Report Question 7.115
Brain metastases
Brainstem gliomas in children and adolescents hyperfractionation prognostic factors chemotherapy incidence rate radiation therapy
Breast cancer
Cardiac tumors adjuvant radiation therapy management primary pericardial tumor common median survival rate toxicities with irradiation therapy
Cervical cancer
Chemoradiation Answer 1.12_2 Question 1.12_2
CHOD chemotheraphy
Cholangiocarcinoma histologic variant mayo clinic liver transplant selection criteria and protocol resectability of role for SBRT in higher risk factor for recurrence incidence rate radiation therapy for risk factors for signs and symptoms
CNS radiation toxicities/therapies for toxicities bevacizumab classification of radiation injury following radiation of spinal cord phenytoin Cahan's criteria for radiation-induced neoplasm donepezil methylphenidate risk of optic neuropathy
Craniopharyngioma cyst management histologies long-term outcomes of prognostic features radiosurgery (SRS) survival rates endocrine abnormalities incidence rate primary management radiation therapy resection of
CSI
cyclophosphamide, doxorubicin, vincristine, and dexamethasone (CHOD) chemotherapy Question 2.69 Answer 2.69
Donepezil Question 2.100 Answer 2.100
Early stage breast cancer
Ependymoma adjuvant conformal radiotherapy, outcome of histological subtypes location for prognostic factors surgical resection treatment, outcome of common location for pediatric intracranial pathological features radiation therapy
Ewing's sarcoma cellular morphology local vs metastatic, survival rate phase III INT-0091 study radiographic findings incidence rate osteosarcoma and prognostic factors treatment approach
FLIPI
Follicular Lymphoma International Prognostic Index (FLIPI) Answer 8.19 Answer 8.18 Answer 8.20
Gastric cancer